We next assessed the ability of Spike-LP-GMP vaccine to protect against lethal challenge with SARS-CoV-2 WA-1 or delta strains in K18-hACE transgenic mice that express human ACE-2, which develop lethal COVID-19-like disease25. This evidence concerns the gene ACE2 and COVID-19.